Register now

Special Symposia


3D-printed personalized orthopaedic implants

Prof. Holger Jahr
, RWTH Aachen, Germany
Dr. Chris Arts, Maastricht University Medical Center, The Netherlands

Prof. Amir Zadpoor
Delft University of Technology
the Nethertlands
Dr. Jan Schrooten
Additive manufacturing of polylactides, from idea to commercialization
Prof. Dirk Grijpma
, University of Twente, The Netherlands
Dr. Bas van Leeuwen, Corbion Biomaterials, The Netherlands
Mr. Srinivas Varun
Maastricht University
the Netherlands
Dr. Carlos Carvalho
Biofabrication and biomaterials for advanced tissue grafts and models
Dr. Carlos Mota
, Maastricht University, The Netherlands
Dr. Riccardo Levato, University Medical Center Utrecht, The Netherlands

Prof. Jason Burdick 
University of Pennsylvania
United States of America

Dr. Aleksandr Ovsianikov
Vienna University of Technology
Biomaterials based on colloidal building blocks
Prof. Jürgen Groll
, University of Würzburg, Germany
Dr. Sander Leeuwenburgh, Radboud University Medical Center, The Netherlands
Prof. Aldo Boccaccini
University of Erlangen-Nuremberg
Prof. Liam Grover
University of Birmingham 
United Kingdom

Bio-molecular self-assembly for biomaterials design

Prof Aline Miller,
Manchester Institute of Biotechnology, School of Chemical Engineering, University of Manchester
Dr. Jacek Wychowaniec, NanoBioMedical Centre PoznaƄ, Poland 

Prof. Alberto Saiani
University of Manchester
United Kingdom
Prof. Sebastien Lecommandoux
ENSCBP Bordeaux
Computational tools for biomaterials
Dr. Aurélie Carlier,
Maastricht University, The Netherlands
Prof. Jan de Boer, Maastricht University, The Netherlands 

Dr. Andrew Hook
University of Nottingham
United Kingdom 

Prof. Liesbet Geris
Catholic University Louvain

CSB - ESB session
Prof. Michael Buschmann 
George Mason University
United States of America
Drug-Free antibacterial hybrid biopolymers for medical applications 
Prof. Ipsita Roy
, University of Westminster, United Kingdom
Prof. Xiang Zhang, University of Cambridge, United Kingdom
Prof. Xiang Zhang
University of California
United States of America 
Prof. Ipsita Roy
University of Westminster
United Kingdom
Prof. Aldo Boccaccini
University of Erlangen-Nuremberg
Prof. Gianluca Ciardelli
Politecnico di Torino
Dr. Jochen Salber
University Hospital Knappschaftskrankenhaus Bochum
Electrically active biomaterials: the future of translatable bioelectronics 
Manus Biggs, 
National University of Ireland Galway, Ireland
Rylie Green, Imperial College London, United Kingdom
Dr. Roozbeh Ghaffari
Northwestern University
United States of America 
Prof. David Martins
University of Delaware
United States of America 

KSBM-ESB session

Prof. In-sup Noh
Seoul National University of Science and Technology
South Korea
Prof. Sandra Van Vlierberghe
Ghent University 
Nanostructured biomaterials for cell regulation
Prof. Molly Stevens
, Imperial College London, United Kingdom
Dr. Lino Ferreira, University of Coimbra, Portugal
Prof. Molly Stevens
Imperial College London
United Kingdom 
Dr. Lino Ferreira
University of Coimbra
RSC biomaterials chemistry group at ESB
Prof. Chris Sammon
, Sheffield Hallam University, United Kingdom
Prof. Alberto Saiani, University of Manchester, United KIngdom
Prof. Cameron Alexander
University of Nottingham
United Kingdom
Prof. Stephen Rimmer
University of Bradford
United Kingdom 


Translational Research Symposium 

The future of emerging and smart technologies for healthcare in Europe


1st Session: the industry vision

Background & Introduction; Innovation player perspective followed up by a panel discussion: SMEs, Large Companies, Universities & ESTHER

  • Introduction on ESTHER (Patrick Boisseau, CEATech, Grenoble, France)
  • The vision from healthtech industry (Serge Bernasconi, Medtech Europe, Brussels, Belgium)
  • A SME perspective (Philip Procter, GPBio Ltd, Ireland)
  • A multinational perspective (Yves Bayon, Medtronic, France)
  • Panel discussion: the EU innovation ecosystem in healthcare?

2nd Session: a patient centric perspective

Patient & Clinical perspective followed up by a panel discussion: associations of patients, clinicians, clinical networks, clusters

  • What do clinicians expect from industry and from technology in regenerative medicine? (Hans Jörg Meisel, Director Center of Neurosciences, Bergmannstrost, Berlin, Germany)
  • From lab to OR in nanomedicine (Didier Letourneur, INSERM and Hospital Bichat, Paris, France)
  • The European cooperation of clinical centers (Christine Kubiak, ECRIN ERIC, Paris, France)
  • The patient’s perspective (Estelle ARTZNER-LECOINTE, SPAEN)
  • Panel discussion: the empowerment of patient in health technologies innovation

3rd Session: what is the vision of healthcare beyond 2020?

Open forum on expectations of FP9 EU calls by the Biomaterials Research Community, stakeholders of clinical translation of biomaterials and ESTHER

  • The ESB perspective on FP9 (Matteo Santin, University of Brighton, ESB, United Kingdom)
  • The concept of mission (Fergal Donnelly, EC-DG RTD, Brussels, Belgium)
  • Healthtech 2030 (Klaus-Michael Weltring, Bioanalytik-muenster, Münster, Germany)

4th session

  • Elevator pitch